These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10470987)

  • 21. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both?
    Anthonio RL; van Veldhuisen DJ; van Gilst WH
    J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S1-8. PubMed ID: 9731689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.
    Mulder P; Compagnon P; Devaux B; Richard V; Henry JP; Elfertak L; Wimart MC; Thibout E; Comoy E; Macé B; Thuillez C
    Fundam Clin Pharmacol; 1997; 11(3):221-30. PubMed ID: 9243253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
    Vantrimpont P; Rouleau JL; Wun CC; Ciampi A; Klein M; Sussex B; Arnold JM; Moyé L; Pfeffer M
    J Am Coll Cardiol; 1997 Feb; 29(2):229-36. PubMed ID: 9014971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a new angiotensin-converting enzyme inhibitor (idrapril) in rats with left ventricular dysfunction after myocardial infarction.
    Jeremic G; Masson S; Luvara G; Porzio S; Lagrasta C; Riva E; Olivetti G; Latini R
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):347-54. PubMed ID: 8907795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
    Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
    Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
    Guo X; Wang J; Elimban V; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?
    Sugie T; Kagaya Y; Takeda M; Yahagi H; Takahashi C; Takahashi J; Ninomiya M; Watanabe J; Ichinohasama R; Tezuka F; Shirato K
    Cardiovasc Res; 2003 Jun; 58(3):611-20. PubMed ID: 12798434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?
    Haber HL; Simek CL; Gimple LW; Bergin JD; Subbiah K; Jayaweera AR; Powers ER; Feldman MD
    Circulation; 1993 Oct; 88(4 Pt 1):1610-9. PubMed ID: 8104738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
    Machackova J; Sanganalmath SK; Barta J; Dhalla KS; Dhalla NS
    Cardiovasc Toxicol; 2010 Mar; 10(1):9-16. PubMed ID: 19949891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation.
    Nemoto S; Hamawaki M; De Freitas G; Carabello BA
    J Am Coll Cardiol; 2002 Jul; 40(1):149-54. PubMed ID: 12103269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple ACE-ECE-NEP inhibition in heart failure: a comparison with ACE and dual ECE-NEP inhibition.
    Mellin V; Jeng AY; Monteil C; Renet S; Henry JP; Thuillez C; Mulder P
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):390-7. PubMed ID: 16116347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
    Azevedo ER; Newton GE; Parker JD
    J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.
    Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
    Chest; 2005 Sep; 128(3):1812-21. PubMed ID: 16162791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.